AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Clin Nutr 89: 617-623, 2009. First published December 23, 2008; doi:10.3945/ajcn.2008.26918
 American Journal of Clinical Nutrition, doi:10.3945/ajcn.2008.26918
Vol. 89, No. 2, 617-623, February 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/2/617    most recent
ajcn.2008.26918v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Mierlo, L. A.
Right arrow Articles by Draijer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Mierlo, L. A.
Right arrow Articles by Draijer, R.
Agricola
Right arrow Articles by van Mierlo, L. A.
Right arrow Articles by Draijer, R.
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies

Linda AJ van Mierlo1,2,3, Mettina MG Koning1,2,3, Kim van der Zander1,2,3 and Richard Draijer1,2,3

1 From the Unilever Food & Health Research Institute, Vlaardingen, Netherlands.

2 Supported by Unilever Food & Health Research Institute, Vlaardingen, Netherlands.

3 Reprints not available. Address correspondence to LAJ van Mierlo, Unilever Food & Health Research Institute, Vlaardingen, Netherlands. E-mail: linda-van.mierlo{at}unilever.com.

Background: Dietary factors directly influence blood pressure (BP). The lactotripeptides (LTPs) IPP (isoleucine-proline-proline) and VPP (valine-proline-proline), formed by hydrolyzing dairy proteins, and potassium, a mineral mainly found in fruit, vegetables, and dairy products, are extensively studied for their BP-lowering effect. The efficacy of LTPs seems modest in whites compared with that in Asians.

Objective: The objective was to study the effects of enzymatically produced LTPs alone or in combination with potassium on ambulatory BP in whites.

Design: Two multicenter, placebo-controlled, randomized, crossover studies were conducted; each consisted of two 4-wk intervention periods separated by a 4-wk washout period. In study 1, 69 subjects received 200 g/d of a dairy drink with 5.8 mg IPP and 4.4 mg VPP or placebo. In study 2, 93 subjects received 100 g/d of a dairy drink with 2.7 mg IPP, 1.9 mg VPP, and 350 mg added K or placebo. The subjects were randomly assigned according to their daytime ambulatory BP.

Results: Mean 24-h systolic and diastolic BP (baseline values—study 1: 137.1/81.6 mm Hg; study 2: 139.2/80.9 mm Hg) remained similar with no significant differences between treatments in either study (P > 0.10). Office BP decreased over the course of both studies (systolic BP > 5 mm Hg), but differences between interventions were not significant (P > 0.10). In both studies, nighttime BP dipped during all treatments (≥15%) but was statistically more significant with placebo (P < 0.05). Sodium excretion increased significantly after consumption of LTPs and potassium compared with after placebo intervention (P = 0.01), but not after consumption of LTPs alone.

Conclusion: The data do not support a BP-lowering effect of LTPs in whites.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society for Nutrition